Evolent Health, Inc.
EVH· NYSE
Released Feb 22, 2023, after the close
10-K filed Feb 24, 2023, 55 days after period end · 0001628908-23-000029
| Metric | Q4 2022 | Q4 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $382.43M | $248.36M | $271.92M | $236.53M |
| Net Income | -$11.35M | -$5.65M | -$14.63M | -$198.10M |
| EPS Diluted |
Evolent Health, Inc. · CIK 1628908 · Engraved from SEC EDGAR
| -$0.11 |
| $0.03 |
| -$0.13 |
| -$2,360.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.